DCGI has approved a phase 2 and 3 clinical trial of Covaxin for minors

The Drugs Controller General of India (DCGI) has authorised phase 2 and 3 clinical trials of Bharat Biotech's Covaxin vaccine in children aged 2 to 18.

Read More
... India will produce over 2 billion doses
... ICSE and ISC students grades can be determined by their performance in online class
... Lockdown extended in Maharashtra
... For the next five days, Mumbai will have a 10% water cut.
... Covid vaccinatiion is not available for people aged 18 to 40 in Maharashtra